International Health Technology Assessments and Their Impact on Access and Patient Preferences

  • October 14, 2021 - 12:00pm - 1:00pm

Exploring health technology assessment approaches used outside of the United States and the impact a national health technology assessment entity could have on U.S. patient access and innovation.    

Advocacy Exchange

International Health Technology Assessments and Their Impact on Access and Patient Preferences | October 14, 2021 

The Advocacy Exchange forum explored some of the health technology assessment approaches used outside of the United States and the impact a national health technology assessment entity could have on U.S. patient access and innovation. 

Speakers included key thought leaders and U.S. and international patient advocates:

  • Michael L. Ryan, PharmD, Senior Vice President and Head for U.S. and Worldwide Value, Access, Pricing and Health Economics and Outcomes Research, Bristol Myers Squibb
  • Stephanie Dyson, Vice President, U.S. Policy & Government Affairs, Bristol Myers Squibb
  • Elizabeth Franklin, PhD, MSW, President, Cancer Support Community
  • Dr. Androulla Eleftheriou, Executive Director, Thalassaemia International Federation
  • John M. O'Brien, PharmD, MPH, President and CEO, National Pharmaceutical Council

For additional information on the program, visit the event website.